Ruxolitinib Remains Backbone in Myelofibrosis and MPN Treatment

Patients with myelofibrosis and other myeloproliferative neoplasms (MPN) are often able to achieve improved survival outcomes and quality of life following treatment with ruxolitinib (Jakafi), a highly potent and selective…

Opinion | Why the male birth control pill remains a dream

Placeholder while article actions load Susanna Schrobsdorff writes the “It’s Not Just You” newsletter at Substack.com. Women didn’t exactly rush into the streets to celebrate the news last month that…